These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 32520788)
21. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. Veit-Haibach P; Ahlström H; Boellaard R; Delgado Bolton RC; Hesse S; Hope T; Huellner MW; Iagaru A; Johnson GB; Kjaer A; Law I; Metser U; Quick HH; Sattler B; Umutlu L; Zaharchuk G; Herrmann K Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3513-3537. PubMed ID: 37624384 [TBL] [Abstract][Full Text] [Related]
22. A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary. Küronya Z; Sinkovics I; Ágoston P; Bíró K; Bodrogi I; Böde I; Dank M; Gyergyay F; Vajdics T; Kolonics Z; Nagyiványi K; Rúzsa Á; Géczi L Pathol Oncol Res; 2017 Oct; 23(4):777-783. PubMed ID: 28074331 [TBL] [Abstract][Full Text] [Related]
23. Nursing management of patients with castration-resistant prostate cancer undergoing radium-223 dichloride treatment. Delacruz A; Arauz G; Curley T; Lindo A; Jensen T Clin J Oncol Nurs; 2015 Apr; 19(2):E31-5. PubMed ID: 25840395 [TBL] [Abstract][Full Text] [Related]
24. Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration. Frantellizzi V; Pontico M; Pani A; Pani R; De Vincentis G Curr Radiopharm; 2020; 13(2):159-163. PubMed ID: 31560295 [TBL] [Abstract][Full Text] [Related]
25. Practical guide to the use of radium 223 dichloride. Den RB; Doyle LA; Knudsen KE Can J Urol; 2014 Apr; 21(2 Supp 1):70-6. PubMed ID: 24775727 [TBL] [Abstract][Full Text] [Related]
26. ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy. Shih HA; Rengan R; Apisarnthanarax S; Cheng CW; Daartz J; DeLaney TF; Hartsell WF; Indelicato DJ; Keole SR; Rosenthal S; Hartford AC Am J Clin Oncol; 2020 Mar; 43(3):149-159. PubMed ID: 32028342 [TBL] [Abstract][Full Text] [Related]
27. Radium Ra 223 dichloride in castration-resistant prostate cancer. Joung JY; Ha YS; Kim IY Drugs Today (Barc); 2013 Aug; 49(8):483-90. PubMed ID: 23977665 [TBL] [Abstract][Full Text] [Related]
28. Radium-223 dichloride in clinical practice: a review. Florimonte L; Dellavedova L; Maffioli LS Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1896-909. PubMed ID: 27121689 [TBL] [Abstract][Full Text] [Related]
29. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633 [TBL] [Abstract][Full Text] [Related]
30. Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer. Picciotto M; Franchina T; Russo A; Ricciardi GRR; Provazza G; Sava S; Baldari S; Caffo O; Adamo V Expert Opin Pharmacother; 2017 Jun; 18(9):899-908. PubMed ID: 28449621 [TBL] [Abstract][Full Text] [Related]
31. New treatment option: 223Ra chloride, the first approved unsealed α-emitting radiopharmaceutical. Colletti PM Clin Nucl Med; 2013 Sep; 38(9):724-5. PubMed ID: 23867617 [TBL] [Abstract][Full Text] [Related]
32. EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer. Poeppel TD; Handkiewicz-Junak D; Andreeff M; Becherer A; Bockisch A; Fricke E; Geworski L; Heinzel A; Krause BJ; Krause T; Mitterhauser M; Sonnenschein W; Bodei L; Delgado-Bolton RC; Gabriel M Eur J Nucl Med Mol Imaging; 2018 May; 45(5):824-845. PubMed ID: 29234845 [TBL] [Abstract][Full Text] [Related]
33. Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer? Dorff TB; Gross ME Am Soc Clin Oncol Educ Book; 2015; ():e270-3. PubMed ID: 25993185 [TBL] [Abstract][Full Text] [Related]
34. The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis. Suominen MI; Wilson T; Käkönen SM; Scholz A Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405099 [TBL] [Abstract][Full Text] [Related]
35. Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why. Gallicchio R; Mastrangelo PA; Nardelli A; Mainenti PP; Colasurdo AP; Landriscina M; Guglielmi G; Storto G Tumori; 2019 Oct; 105(5):367-377. PubMed ID: 31096849 [TBL] [Abstract][Full Text] [Related]
36. Treatment landscape of metastatic prostate cancer: the role of radium-223. Dermine A; Machiels JP Acta Clin Belg; 2017 Feb; 72(1):19-23. PubMed ID: 27377415 [TBL] [Abstract][Full Text] [Related]
37. Retrospective Toxicological Profiling of Radium-223 Dichloride for the Treatment of Bone Metastases in Prostate Cancer Using Adverse Event Data. Soldatos TG; Iakovou I; Sachpekidis C Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31100964 [No Abstract] [Full Text] [Related]
38. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS). Seung SK; Larson DA; Galvin JM; Mehta MP; Potters L; Schultz CJ; Yajnik SV; Hartford AC; Rosenthal SA Am J Clin Oncol; 2013 Jun; 36(3):310-5. PubMed ID: 23681017 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic effect of RA223 in the management of breast cancer bone metastases. Costa RP; Tripoli V; Princiotta A; Murabito A; Licari M; Piazza D; Verderame F; Pinto A Clin Ter; 2019; 170(1):e1-e3. PubMed ID: 30789190 [TBL] [Abstract][Full Text] [Related]
40. [Radium dichloride-223 improves symptoms including in the daily clinic]. Kirchner V; Papazyan JP Rev Med Suisse; 2015 Nov; 11(493):2083. PubMed ID: 26685654 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]